Doximity (DOCS) Price & Analysis

Compare

867 Followers

DOCS Stock Chart & Stats

Day’s Range― - ―

52-Week Range$36.12 - $85.21

Previous CloseN/A

Volume296.07K

Average Volume (3M)1.63M

Market Cap

$12.99B

Enterprise Value$11.51B

Total Cash (Recent Filing)$840.97M

Total Debt (Recent Filing)$11.84M

Price to Earnings (P/E)59.7

Beta1.33

Next Earnings

Nov 06, 2025

EPS Estimate

0.37

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.36

Shares Outstanding136,400,250

10 Day Avg. Volume1,114,404

30 Day Avg. Volume1,628,948

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap0.89

Enterprise Value/Revenue19.52

Enterprise Value/Gross Profit21.65

Enterprise Value/Ebitda44.42

Forecast

1Y Price Target

$67.73

Price Target Upside-2.57% Downside

Rating ConsensusModerate Buy

Number of Analyst Covering16

Bulls Say, Bears Say

Bulls Say

Customer EngagementDOCS has built a comprehensive workflow for clinicians, enhancing its service offerings and customer engagement.

Financial PerformanceDOCS reported excellent F1Q:26 results with revenue and adjusted EBITDA well ahead of consensus estimates.

Product InnovationDOCS continues to innovate with new AI products, solidifying its position as a strategic partner in the bio-pharma industry.

Bears Say

Conservative GuidanceRevised FY'26 guidance continues to contemplate significant conservatism with implied revenue growth of ~7% year-over-year in the second half of FY'26.

Stock CompensationStock compensation dilution from Pathway acquisition and large incentive awards for AI development are expected to rise to high-teens percentage of revenue in FY'26-FY'27.

Doximity News

Doximity could be impacted by FDA ad crackdown, says Raymond James

HHS and the FDA announced new enforcement actions against misleading direct-to-consumer pharmaceutical advertising, issuing thousands of warning letters...

4h ago

DOCS

Doximity Holds Annual Stockholders Meeting, Elects Directors

Doximity ( ($DOCS) ) just unveiled an announcement. On August 28, 2025, Doximity, Inc. held its Annual Meeting...

8d ago

DOCS

Doximity Announces Leadership Change with New Appointments

An update from Doximity ( ($DOCS) ) is now available. On August 13, 2025, Doximity announced that its...

26d ago

DOCS

Doximity’s Strong Market Position and AI-Driven Growth Reinforce Buy Rating

Doximity, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Cherny from Leerink...

26d ago

DOCS

Doximity’s Earnings Call Highlights Growth and AI Advances

Doximity, Inc. (($DOCS)) has held its Q1 earnings call. Read on for the main highlights of the call....

29d ago

DOCS

Doximity price target raised to $75 from $67 at Needham

Needham raised the firm’s price target on Doximity (DOCS) to $75 from $67 and keeps a Buy rating...

1M ago

DOCS

Doximity price target raised to $62 from $60 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Doximity (DOCS) to $62 from $60 and keeps an Equal...

1M ago

DOCS

Doximity price target raised to $75 from $65 at Raymond James

Raymond James raised the firm’s price target on Doximity (DOCS) to $75 from $65 and keeps an Outperform...

1M ago

DOCS

Doximity price target raised to $65 from $62 at Wells Fargo

Wells Fargo raised the firm’s price target on Doximity (DOCS) to $65 from $62 and keeps an Equal...

1M ago

DOCS

Doximity price target raised to $59 from $50 at Canaccord

Canaccord analyst Richard Close raised the firm’s price target on Doximity (DOCS) to $59 from $50 and keeps...

1M ago

DOCS

Doximity’s Strong Q1 and AI Innovations Drive Buy Rating Despite Growth Concerns

In a report released today, Ryan MacDonald from Needham maintained a Buy rating on Doximity, with a price...

1M ago

DOCS

Doximity Reports Strong Q1 Earnings with Revenue Growth

Doximity, Inc. ( ($DOCS) ) has released its Q1 earnings. Here is a breakdown of the information Doximity,...

1M ago

DOCS

Closing Bell Movers: Expedia, TripAdvisor jump on Q2 earnings beats

In the opening hour of the evening session, U.S. equity futures are up slightly, with S&P 500 e-minis,...

1M ago

Doximity’s Strong Financial Performance and Strategic AI Acquisition Justify Buy Rating

William Blair analyst Ryan Daniels has maintained their bullish stance on DOCS stock, giving a Buy rating on...

1M ago

DOCS

DOCS FAQ

What was Doximity’s price range in the past 12 months?

Doximity lowest stock price was $36.12 and its highest was $85.21 in the past 12 months.

What is Doximity’s market cap?

Doximity’s market cap is $12.99B.

When is Doximity’s upcoming earnings report date?

Doximity’s upcoming earnings report date is Nov 06, 2025 which is in 57 days.

How were Doximity’s earnings last quarter?

Doximity released its earnings results on Aug 07, 2025. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.302 by $0.058.

Is Doximity overvalued?

According to Wall Street analysts Doximity’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Doximity pay dividends?

Doximity does not currently pay dividends.

What is Doximity’s EPS estimate?

Doximity’s EPS estimate is 0.37.

How many shares outstanding does Doximity have?

Doximity has 136,400,250 shares outstanding.

What happened to Doximity’s price movement after its last earnings report?

Doximity reported an EPS of $0.36 in its last earnings report, beating expectations of $0.302. Following the earnings report the stock price went up 13.715%.

Which hedge fund is a major shareholder of Doximity?

Currently, no hedge funds are holding shares in DOCS

Doximity Stock Smart Score

Outperform

Fundamentals

Return on Equity

24.25%

Trailing 12-Months

Asset Growth

12.20%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Doximity

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Doximity (DOCS) Earnings & Revenues

Historic Earnings Reports

DOCS Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call presented a largely positive outlook with strong financial performance, significant user growth, and successful product launches. However, there are concerns regarding policy uncertainties and the lack of immediate revenue contribution from recent acquisitions.View all DOCS earnings summaries

DOCS Revenue Breakdown

93.00% Subscription

7.00% Other

DOCS Stock 12 Month Forecast

Average Price Target

$67.73

▼(-2.57% Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"26":"$26","81":"$81","39.75":"$39.8","53.5":"$53.5","67.25":"$67.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":80,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$80.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":67.73,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$67.73</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":57,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$57.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[26,39.75,53.5,67.25,81],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,57.33,59.073846153846155,60.817692307692305,62.56153846153846,64.30538461538461,66.04923076923077,67.79307692307692,69.53692307692307,71.28076923076924,73.02461538461539,74.76846153846154,76.5123076923077,78.25615384615385,{"y":80,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,57.33,58.129999999999995,58.93,59.73,60.53,61.33,62.13,62.93,63.730000000000004,64.53,65.33,66.13000000000001,66.93,{"y":67.73,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,57.33,57.30461538461538,57.279230769230765,57.253846153846155,57.22846153846154,57.20307692307692,57.177692307692304,57.152307692307694,57.12692307692308,57.10153846153846,57.076153846153844,57.050769230769234,57.02538461538462,{"y":57,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":27.39,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.78,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.2,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.35,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.41,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.39,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.1,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.5,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.72,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.07,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.5,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.38,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.33,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >